ionnaire at T0.
5.1 Economic indicators (T0, T1, T2, T3) and barriers to accessing health care (T0) (for cost-benefit and health-system analyses), measured using survey questions designed for this study - partly based on the Client Service Receipt Inventory (CSRI)
5.2 Treatment contamination check, measured using survey questions designed for this study (T1, T2)
All outcomes are assessed by a masked team of interviewers not involved in service delivery.
Overall trial start date
Overall trial end date
Reason abandoned (if study stopped)
Participant inclusion criteria
1. Aged between 10 and 14 years;
2. Reside with a caregiver who is able to provide consent;
3. Able and willing to commit to attending the weekly EASE sessions;
4. Screens positive for psychological distress during screening (using 17 item PSC).
5. Children of any nationality and background will be eligible.
Target number of participants
Participant exclusion criteria
1. Unaccompanied minor;
2. Caregiver is not a family member, as they would not be able to provide legal consent;
3. Significant cognitive impairment or severe neurological impairments or developmental difficulties as determined by caregiver-report during screening, where this would impair their ability to participate in a group programme;
4. Imminent risk of suicide;
5. Currently married.
Recruitment start date
Recruitment end date
Countries of recruitment
Trial participating centre
War Child Holland
Hussein Oueini Street
European Commission (H2020)
European Union, EC
Funding Body Type
Funding Body Subtype
Results and Publications
Publication and dissemination plan
Planned publication in a high-impact peer reviewed journal
IPD sharing statement:
The datasets generated during and/or analysed during the current study are/will be available upon request from Mark Jordans, War Child Holland
Intention to publish date
Participant level data
Available on request
Basic results (scientific)